MiR-210-3p Enhances Cardiomyocyte Apoptosis and Mitochondrial Dysfunction by Targeting the NDUFA4 Gene in

Dandan Chen1, Yu Hou1, Xingjun Cai2

  • 1Department of Critical Care Medicine, Affiliated Haikou Hospital of Xiangya Medical College, Central South University.

Insights

MicroRNA-210-3p exacerbates sepsis-induced myocardial dysfunction by promoting cardiomyocyte apoptosis and mitochondrial damage. Targeting this microRNA may offer a therapeutic strategy for sepsis patients.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Sepsis-induced myocardial dysfunction (SIMD) is a critical complication in sepsis patients.
  • Understanding the molecular mechanisms underlying SIMD is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of microRNA-210-3p (miR-210-3p) in regulating cardiomyocyte apoptosis and mitochondrial dysfunction in SIMD.
  • To elucidate the molecular targets and pathways affected by miR-210-3p in SIMD pathogenesis.

Main Methods:

  • Established a rat sepsis model using cecal ligation and puncture.
  • Assessed serum inflammatory factors, myocardial apoptosis, and miR-210-3p expression.
  • Utilized in vitro cell culture (H9C2 cells) with miR-210-3p mimics/inhibitors to evaluate cell viability, reactive oxygen species (ROS) production, and apoptosis.
  • Validated the direct binding of miR-210-3p to NDUFA4 using a dual luciferase reporter assay.

Main Results:

  • Septic rats exhibited elevated inflammatory markers (TNF-α, IL-6), myocardial injury, apoptosis, and altered Bcl-2/Caspase-1 levels.
  • Septic serum impaired H9C2 cell viability, increased ROS, and induced apoptosis.
  • miR-210-3p expression was significantly upregulated in septic myocardial tissues and H9C2 cells.
  • miR-210-3p directly targets NDUFA4, and its upregulation exacerbates SIMD-related cellular and mitochondrial dysfunction.

Conclusions:

  • miR-210-3p plays a pro-apoptotic and pro-dysfunction role in sepsis-induced myocardial dysfunction.
  • Targeting miR-210-3p may represent a novel therapeutic approach for managing SIMD.

Related Concept Videos